"Elraglusib with chemotherapy and immune priming represents a novel sequential therapy approach to treat advanced salivary cancers. We were encouraged by the response rate among the non-Adenoid ...

Actuate Therapeutics, Inc. announced that data on their investigational drug elraglusib, designed to treat advanced salivary gland carcinoma by inhibiting glycogen synthase kinase-3 beta (GSK-3β ...

It is possible that the patient had a mucosal radiation reaction to the 131 I, which was concentrated in the oral cavity by secretions from all the major and minor salivary glands. An ...

1 Department of Oral Medicine & Radiology, Mythri College of Dentistry & Medical Sciences, Durg, India 2 Department of Oral Medicine & Radiology, People’s College of Dental Sciences & Research Centre, ...

“Elraglusib with chemotherapy and immune priming represents a novel sequential therapy approach to treat advanced salivary cancers. We were encouraged by the response rate among the non-Adenoid Cystic ...